Which antidepressants or anxiolytics, including selective serotonin reuptake inhibitors (SSRIs), have minimal impact on sexual function for an adult patient with depression or anxiety who wants to preserve orgasm?

Antidepressants with Minimal Impact on Sexual Function and Orgasm

Bupropion is the clear first-line choice when preserving sexual function and orgasm is a priority, with sexual dysfunction rates of only 8-10% compared to 58-73% with SSRIs. 1

Evidence-Based Ranking by Sexual Dysfunction Risk

Lowest Risk (Recommended)

• Bupropion: 8-10% sexual dysfunction rate—significantly lower than all SSRIs 1, 2

  • Direct comparison studies show 15% dysfunction in men and 7% in women on bupropion versus 63% in men and 41% in women on sertraline 3
  • Maintains orgasmic function better than any SSRI 4
  • Maximum dose: 450 mg/day (extended-release formulation) 1

• Mirtazapine: 24.4% sexual dysfunction rate 5

  • Lower than SSRIs but causes significant sedation and weight gain 1, 2
  • May be beneficial if insomnia or poor appetite coexist 1

• Nefazodone: 8% sexual dysfunction rate 5

  • Comparable to bupropion but less commonly prescribed 4

Moderate Risk (Use with Caution)

• Sertraline: 62.9% overall sexual dysfunction; 14% ejaculatory failure, 6% decreased libido 1, 5
• Fluoxetine: 57.7% sexual dysfunction 5
• Citalopram/Escitalopram: 72.7% sexual dysfunction for citalopram 5

Highest Risk (Avoid)

• Paroxetine: 70.7% sexual dysfunction—the highest among all antidepressants 1, 2, 5

  • Provides strongest ejaculation delay but severely impairs other aspects of sexual function 1
  • Should be completely avoided when sexual function is a concern 1

• Venlafaxine (SNRI): 67.3% sexual dysfunction 5

Clinical Decision Algorithm

Step 1: Initial Treatment Selection

Start with bupropion 150-300 mg/day (sustained-release) if depression or anxiety requires pharmacological treatment and sexual function is a major concern. 1, 3

Step 2: Contraindications to Bupropion

Do not use bupropion in patients with: 1, 2

• Seizure disorders or history of seizures
• Eating disorders (bulimia, anorexia nervosa)
• Significant agitation or anxiety (may worsen symptoms)
• Abrupt alcohol or benzodiazepine discontinuation

If bupropion is contraindicated, use mirtazapine 15-30 mg/day as second choice. 1

Step 3: If Already on an SSRI with Sexual Dysfunction

Switch to bupropion rather than adding adjunctive agents. 1, 4

• Taper the SSRI appropriately (fluoxetine requires 10-14 days) 1
• Monitor for SSRI discontinuation symptoms during transition 2
• Reassess sexual function within 1-2 weeks of achieving therapeutic bupropion dose 1

Step 4: If Switching is Not Feasible

For men with erectile dysfunction specifically, add a PDE5 inhibitor (sildenafil or tadalafil) to the existing SSRI. 2

• This addresses erectile function but does not improve libido or orgasmic dysfunction 2
• Contraindicated with nitrate use 2

Critical Safety Considerations

Bupropion-Specific Warnings

• Seizure risk increases at doses >300 mg/day 2
• Seizure risk is dose-dependent and increases with predisposing factors 2
• Use extended-release formulations to minimize seizure risk 1

Important Clinical Caveats

• Sexual dysfunction rates are vastly underreported in clinical trials—real-world incidence is significantly higher than published figures 1
• Approximately 40% of patients show low tolerance of sexual dysfunction, contributing to treatment discontinuation 1
• Sexual side effects emerge within the first few weeks of SSRI treatment 1
• Directly ask patients about sexual function at every visit—patients rarely volunteer this information 1

Anxiety Disorder Considerations

For generalized anxiety disorder specifically, SSRIs and SNRIs remain first-line per guidelines, but bupropion has comparable efficacy for anxiety when depression is the primary diagnosis. 6, 7

• If anxiety is the primary diagnosis without depression, cognitive behavioral therapy should be strongly considered as it has similar efficacy to SSRIs without sexual side effects 6
• SSRIs have established efficacy for social anxiety disorder, but sexual dysfunction remains a significant limitation 6

What Does NOT Work

Buspirone augmentation has no evidence supporting its use for SSRI-induced sexual dysfunction and should not be used for this indication. 1

Monitoring Timeline

• Assess sexual function at baseline before starting any antidepressant 1
• Re-assess within 1-2 weeks of treatment initiation 1, 2
• If sexual dysfunction emerges, switch medications rather than waiting—dysfunction persists throughout treatment 3
• If no improvement in sexual function within 6-8 weeks of switching, consider alternative strategies 1